Sent from my iPad Begin forwarded message:
From: Genetic Engineering & Biotechnology News <gen@genmail.co> Date: April 11, 2025 at 11:03:33 AM GMT-3 To: mxh5000@gmail.com Subject: Six Ways to Turbocharge U.S. Biotech Innovation Against the Threat from China Outlined by National Commission Reply-To: gen@genmail.co
View in browser
TOP STORIES Friday, April 11, 2025
National Commission Outlines Six Ways to Turbocharge U.S. Biotech Innovation Against the Threat from China
To prevent dominance by an acknowledged adversary, the National Security Commission on Emerging Biotechnology (NSCEB) calls for a two-track strategy that helps American companies innovate more quickly and slows China’s rate of advance. Its point-of-no-return timeline is three years. + MORE
Key Neural Pain-Sensing Pathway Recreated in a Lab Dish
Scientists have replicated, in a lab dish, a key nervous pathway for human pain sensation. The investigators suggest their research could improve our understanding of how pain signals are processed in humans and how to alleviate pain. + MORE
Apathy in Cancer Patients Linked to Brain-Immune Circuit
Previous research linked cachexia, a wasting syndrome that is commonly observed in advanced cancer patients, to chronic inflammation and changes in metabolism, but until now, the neural mechanisms behind behavioral symptoms like apathy remained unclear. + MORE
Why CRISPR R&D Needs to Think About Data Workflows
Like a good workbench, proper data systems can help keep gene editing tools organized and accessible, providing the scaffold on which to build better science and better medicines for a range of human diseases. + MORE
Novel Predictive Algorithm Identifies InDel Signatures Associated with Cancer
Using data from Genomics England's 100,000 Genomes Project, scientists from the University of Cambridge and their collaborators developed an algorithm that identifies unique InDel patterns in tumors with faulty DNA repair mechanisms. + MORE
Cellares and University of Wisconsin Agree to Automate Clinical-Scale Production of CRISPR-Edited CAR-T
By enabling the CRISPR-edited GD2 CAR-T project at University of Wisconsin–Madison to achieve clinical-scale manufacturing earlier, the partnership aims to unlock potential investment into the experimental therapy and expedite its path to initial human trials. + MORE
UPCOMING EVENTS The State of Multiomics & NGS
In GEN's virtual summit, we proudly host a magnificent group of talented researchers from industry and academia. In addition, the summit will include breakout sessions from our sponsors and plenty of live audience discussion. + MORE
Effective mAb Aggregate Removal: Evaluating Three Key Chromatography Resins
In this GEN webinar, Alejandro Becerra, PhD, will present results from using an IgG1 post-Protein A pool as a model system to evaluate the aggregate removal capabilities of three Thermo Fisher chromatography resins under typical operating conditions. + MORE
Genetic Engineering & Biotechnology News Mary Ann Liebert, Inc., a Sage Company 140 Huguenot Street New Rochelle, NY 10801 You have received this email at mxh5000@gmail.com Unsubscribe Manage Preferences